CIS
BMY icon

Capital International Sarl’s Bristol-Myers Squibb BMY Stock Holding History

Capital International Sarl’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.44M Buy
94,347
+116
+0.1% +$6.66K 0.08% 154
2026
Q1 		$5.72M Sell
94,231
-8,221
-8% -$479K 0.09% 140
2025
Q4 		$5.53M Sell
102,452
-16,474
-14% -$793K 0.09% 145
2025
Q3 		$5.36M Sell
118,926
-42,797
-26% -$2M 0.09% 143
2025
Q2 		$7.49M Sell
161,723
-12,324
-7% -$605K 0.14% 122
2025
Q1 		$10.6M Buy
174,047
+19,955
+13% +$1.16M 0.24% 99
2024
Q4 		$8.72M Buy
154,092
+37,067
+32% +$2.07M 0.2% 105
2024
Q3 		$6.05M Buy
117,025
+60,888
+108% +$2.86M 0.16% 121
2024
Q2 		$2.33M Sell
56,137
-336,680
-86% -$15.1M 0.07% 163
2024
Q1 		$21.3M Buy
392,817
+44,767
+13% +$2.28M 0.71% 47
2023
Q4 		$17.9M Buy
348,050
+21,296
+7% +$1.12M 0.67% 50
2023
Q3 		$19M Sell
326,754
-33,277
-9% -$2.04M 0.87% 27
2023
Q2 		$23M Buy
360,031
+70,357
+24% +$4.72M 1.03% 19
2023
Q1 		$20.1M Buy
289,674
+170,811
+144% +$12M 1.01% 21
2022
Q4 		$8.55M Buy
118,863
+16,611
+16% +$1.25M 0.6% 57
2022
Q3 		$7.27M Buy
102,252
+55,163
+117% +$4M 0.59% 45
2022
Q2 		$3.63M Sell
47,089
-26,304
-36% -$2M 0.29% 104
2022
Q1 		$5.36M Buy
+73,393
New +$4.93M 0.27% 102
2015
Q3 		– Sell
-173,500
Closed -$11.5M – 178
2015
Q2 		$11.5M Sell
173,500
-199,183
-53% -$13.1M 0.85% 44
2015
Q1 		$24M Sell
372,683
-159,600
-30% -$9.99M 1.75% 14
2014
Q4 		$31.4M Sell
532,283
-31,100
-6% -$1.75M 1.94% 12
2014
Q3 		$28.8M Sell
563,383
-17,350
-3% -$867K 1.71% 12
2014
Q2 		$28.2M Sell
580,733
-311,667
-35% -$15.4M 1.58% 19
2014
Q1 		$46.4M Sell
892,400
-45,500
-5% -$2.42M 2.57% 8
2013
Q4 		$49.8M Sell
937,900
-110,900
-11% -$5.65M 2.67% 7
2013
Q3 		$48.5M Buy
1,048,800
+33,800
+3% +$1.48M 2.77% 6
2013
Q2 		$45.4M Buy
+1,015,000
New +$44.1M 3.2% 5

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Sarl's BMY Position: Q2 2026 in Review

Capital International Sarl increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q2 2026, buying an estimated $6.66K and bringing the position to 94,347 shares worth $5.44M. The position accounts for 0.08% of the portfolio, ranked #154.

Capital International Sarl first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $49.8M in Q4 2013. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Capital International Sarl held 94,347 shares of Bristol-Myers Squibb worth $5.44M as of Q2 2026.
  • Capital International Sarl bought 116 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.66K.
  • Bristol-Myers Squibb made up 0.08% of Capital International Sarl's portfolio in Q2 2026, its #154 holding.
  • Capital International Sarl first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
  • Capital International Sarl's Bristol-Myers Squibb position peaked at $49.8M in Q4 2013.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.